Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer.

Rehman, Hasan; Chi, Jeffrey; Hakim, Nausheen; Goyal, Shreya Prasad; Olazagasti, Coral; Jose, Jyothi; Moriarty, Linda; Saif, Muhammad Wasif

Rehman, Hasan; Chi, Jeffrey; Hakim, Nausheen; Goyal, Shreya Prasad; Olazagasti, Coral; Jose, Jyothi; Moriarty, Linda; Saif, Muhammad Wasif.

Afiliação

Rehman H; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Chi J; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Hakim N; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Goyal SP; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Olazagasti C; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Jose J; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Moriarty L; Northwell Health Cancer Institute, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA.
Saif MW; Northwell Health Cancer Institute, Medical Oncology, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 1111 Marcus Avenue, Lake Success, NY 11042, USA.

Therap Adv Gastroenterol ; 13: 1756284820974912, 2020.

Article em En | MEDLINE | ID: mdl-33281939

Palavras-chave

advanced pancreatic cancer; attenuated regimen; biweekly; chemotherapy; elderly; improved toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Therap Adv Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google